| InspireMD is a medical device company focusing on the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of vascular and coronary disease. Co.'s CGuard carotid embolic prevention system combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Co.'s MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). MGuard Prime EPS combines MicroNet with a bare-metal cobalt-chromium based stent. We show 3 historical shares outstanding datapoints in our coverage of NSPR's shares outstanding history.|
Understanding the changing numbers of NSPR shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NSPR versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NSPR by allowing them to research NSPR shares outstanding history
as well as any other stock in our coverage universe.